95 related articles for article (PubMed ID: 9632840)
1. Age-dependent effect of oral glucocorticoids on markers of bone resorption in patients with acute asthma.
Bornefalk E; Dahlén I; Michaëlsson K; Ljunggren ; Ljunghall S
Calcif Tissue Int; 1998 Jul; 63(1):9-13. PubMed ID: 9632840
[TBL] [Abstract][Full Text] [Related]
2. Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease.
Miyakawa M; Tsushima T; Demura H
Endocr J; 1996 Dec; 43(6):701-8. PubMed ID: 9075610
[TBL] [Abstract][Full Text] [Related]
3. Short-term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide.
Heuck C; Wolthers OD; Hansen M; Kollerup G
Steroids; 1997 Oct; 62(10):659-64. PubMed ID: 9381513
[TBL] [Abstract][Full Text] [Related]
4. [Measurements and clinical usefulness of carboxyterminal propeptide of type I collagen and cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer].
Igawa T; Sakai H; Kanetake H; Saito Y
Hinyokika Kiyo; 1999 Apr; 45(4):235-9. PubMed ID: 10363141
[TBL] [Abstract][Full Text] [Related]
5. Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short-term growth or bone turnover?
Schou AJ; Heuck C; Wolthers OD
Pediatr Pulmonol; 2003 Nov; 36(5):399-404. PubMed ID: 14520722
[TBL] [Abstract][Full Text] [Related]
6. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
Katagiri M; Fukunaga M; Ohtawa T; Harada T
World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
[TBL] [Abstract][Full Text] [Related]
7. Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group.
Kerstjens HA; Postma DS; van Doormaal JJ; van Zanten AK; Brand PL; Dekhuijzen PN; Koëter GH
Thorax; 1994 Jul; 49(7):652-6. PubMed ID: 8066559
[TBL] [Abstract][Full Text] [Related]
8. Bone-turnover metabolites as clinical markers of bone metastasis in patients with prostatic carcinoma.
Takeuchi S; Saitoh H
Int J Urol; 1997 Jul; 4(4):368-73. PubMed ID: 9256326
[TBL] [Abstract][Full Text] [Related]
9. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
[TBL] [Abstract][Full Text] [Related]
10. Cross-sectional evaluation of bone metabolism in men.
Szulc P; Garnero P; Munoz F; Marchand F; Delmas PD
J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833
[TBL] [Abstract][Full Text] [Related]
11. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
12. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
[TBL] [Abstract][Full Text] [Related]
13. [Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type 1 collagen (1CTP)--some basic aspects of the RIA kit and clinical evaluation in various bone diseases].
Yamamoto I; Takada M; Yuu I; Ohnaka Y; Kigami Y; Yamamoto Y; Hamazu H; Morita R
Kaku Igaku; 1993 Nov; 30(11):1411-7. PubMed ID: 8277604
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
[TBL] [Abstract][Full Text] [Related]
15. Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy.
Conti A; Sartorio A; Ferrero S; Ferrario S; Ambrosi B
J Endocrinol Invest; 1996 Feb; 19(2):127-30. PubMed ID: 8778165
[TBL] [Abstract][Full Text] [Related]
16. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of the carboxy-terminal propeptide of type I procollagen and the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen as markers of bone metastases in patients with prostate carcinoma.
Hosoya Y; Arai K; Honda M; Sumi S; Yoshida K
Eur Urol; 1997; 31(2):220-3. PubMed ID: 9076470
[TBL] [Abstract][Full Text] [Related]
18. Effect of low-dose prednisone (with calcium and calcitriol supplementation) on calcium and bone metabolism in healthy volunteers.
Lems WF; Van Veen GJ; Gerrits MI; Jacobs JW; Houben HH; Van Rijn HJ; Bijlsma JW
Br J Rheumatol; 1998 Jan; 37(1):27-33. PubMed ID: 9487247
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
Tsuchida T; Ishimura E; Miki T; Matsumoto N; Naka H; Jono S; Inaba M; Nishizawa Y
Osteoporos Int; 2005 Feb; 16(2):172-9. PubMed ID: 15164161
[TBL] [Abstract][Full Text] [Related]
20. Serum markers of bone metabolism in dogs.
Allen MJ; Hoffmann WE; Richardson DC; Breur GJ
Am J Vet Res; 1998 Mar; 59(3):250-4. PubMed ID: 9522938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
